ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3241

Genetic Variation and Tobacco Smoke Exposure in Systemic Lupus Erythematosus: A Case Control Study Among African Americans

Bethany Wolf1, Paula S. Ramos2, Paul Nietert3, J. Madison Hyer1, Viswanathan Ramakrishnan1, Gary S. Gilkeson4, Gerard Hardiman2 and Diane L. Kamen5, 1Public Health Sciences, Medical University of South Carolina, Charleston, SC, 2Medicine, Medical University of South Carolina, Charleston, SC, 3Public Health Science, Medical University of South Carolina, Charleston, SC, 4Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 5Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: African-Americans, Bioinformatics, genetics and tobacco use, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 16, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis II

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) disproportionately affects African Americans, and the development of SLE is believed to be triggered by exposure to one or more specific environmental factors in genetically susceptible individuals. Tobacco smoke has been implicated as such a potential agent. In this study, we sought to discover whether smoking and/or secondhand smoke inhalation interacts with certain candidate genes, resulting in elevated risk of SLE in African Americans.

Methods: A case control design was used, and all subjects were African Americans of Gullah ancestry, from the Sea Islands of South Carolina or Georgia. All cases met ACR classification criteria for SLE, and all controls were evaluated by a rheumatologist and determined unaffected by autoimmune disease at the time of enrollment. All subjects completed questionnaires to assess smoking history and exposure to secondhand smoke. Candidate genes included ones previously identified in the literature as interacting with tobacco smoke in rheumatic diseases, and genes in the Comparative Toxicogenomics Database that were relevant to tobacco smoke or in an inference network between tobacco smoke and SLE. Genotypic data was available on subjects genotyped on the Illumina Immunochip genotyping array. After standard GWAS quality control, the following were available for analyses: NAT2 (4 single nucleotide polymorphisms [SNPs]), HLA-DRB1 (6 SNPs), APOE (2 SNPs), IL6 (17 SNPs), CXCL8 (1 SNP), IRF5 (20 SNPs), ITGAM (67 SNPs), and ITGAX (31 SNPs). Logic forest, a relatively novel machine learning algorithm we developed, was used to highlight interactions between the environment (i.e. tobacco smoke) and the variants in the candidate genes.

Results:  The study population included 204 participants (n=100 cases, n=104 controls), 86% of whom were female. The logic forest model identified secondhand smoke exposure during childhood as the most important predictor of SLE status. Consistent with the literature, the model identified several SNPs in the IRF5, ITGAM, and ITGAX genes as being risk factors for SLE. Although passive smoke exposure during childhood was of high importance and identified as a main effect, the logic forest detected weak to moderate interactions (odds ratios ranging from 2.3 to 2.5) between it and SNPs in the ITGAM gene.

Conclusion:  In this case-control study, both genetic and environmental risk factors for SLE were identified, with evidence suggesting potential interactions between exposure to secondhand smoke as a child and genetic variation in the ITGAM gene.


Disclosure: B. Wolf, None; P. S. Ramos, None; P. Nietert, None; J. M. Hyer, None; V. Ramakrishnan, None; G. S. Gilkeson, None; G. Hardiman, None; D. L. Kamen, None.

To cite this abstract in AMA style:

Wolf B, Ramos PS, Nietert P, Hyer JM, Ramakrishnan V, Gilkeson GS, Hardiman G, Kamen DL. Genetic Variation and Tobacco Smoke Exposure in Systemic Lupus Erythematosus: A Case Control Study Among African Americans [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/genetic-variation-and-tobacco-smoke-exposure-in-systemic-lupus-erythematosus-a-case-control-study-among-african-americans/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-variation-and-tobacco-smoke-exposure-in-systemic-lupus-erythematosus-a-case-control-study-among-african-americans/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology